fenofibrate and griseofulvin

fenofibrate has been researched along with griseofulvin in 14 studies

Research

Studies (14)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (14.29)29.6817
2010's11 (78.57)24.3611
2020's1 (7.14)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ1
Ekins, S; Williams, AJ; Xu, JJ1
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Jones, LH; Nadanaciva, S; Rana, P; Will, Y1
Hornung, S; Krill, SL; Vippagunta, SR; Wang, Z1
Chen, Y; Chowdhury, SR; Meng, X; Mitra, S; Yang, D1
Bhakay, A; Bilgili, E; Davé, RN; Iqbal, Z; Jerez-Rozo, JI; Michniak-Kohn, B; Pandya, N; Romañach, RJ; Sievens-Figueroa, L1
Dave, RH; Murdande, SB; Shah, DA1
Afolabi, A; Bilgili, E; Davé, RN; Iqbal, Z; Krull, SM; Li, M; Susarla, R; Ying, Y1
Decker, H; Hellmann, N; Johnson, R; Khoshakhlagh, P; Langguth, P; Nawroth, T; Schmueser, L; Szekely, NK1
Xie, Y; Yao, Y1
Brinkmann, J; Luebbert, C; Rest, F; Sadowski, G1

Reviews

1 review(s) available for fenofibrate and griseofulvin

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

13 other study(ies) available for fenofibrate and griseofulvin

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Developing structure-activity relationships for the prediction of hepatotoxicity.
    Chemical research in toxicology, 2010, Jul-19, Volume: 23, Issue:7

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes

2010
A predictive ligand-based Bayesian model for human drug-induced liver injury.
    Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12

    Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands

2010
FDA-approved drug labeling for the study of drug-induced liver injury.
    Drug discovery today, 2011, Volume: 16, Issue:15-16

    Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration

2011
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
    Bioorganic & medicinal chemistry letters, 2016, 08-15, Volume: 26, Issue:16

    Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone

2016
Factors affecting the formation of eutectic solid dispersions and their dissolution behavior.
    Journal of pharmaceutical sciences, 2007, Volume: 96, Issue:2

    Topics: Drug Carriers; Fenofibrate; Flurbiprofen; Griseofulvin; Ibuprofen; Models, Chemical; Molecular Weight; Naproxen; Polyethylene Glycols; Sodium Dodecyl Sulfate; Solubility; Transition Temperature; Water

2007
Stabilizing dispersions of hydrophobic drug molecules using cellulose ethers during anti-solvent synthesis of micro-particulates.
    Colloids and surfaces. B, Biointerfaces, 2009, Apr-01, Volume: 70, Issue:1

    Topics: Cellulose; Colloids; Drug Compounding; Drug Delivery Systems; Ether; Fenofibrate; Griseofulvin; Hydrophobic and Hydrophilic Interactions; Microscopy, Electron, Scanning; Models, Chemical; Particle Size; Solvents; Spectrum Analysis, Raman; Suspensions; Thermodynamics

2009
Preparation and characterization of hydroxypropyl methyl cellulose films containing stable BCS Class II drug nanoparticles for pharmaceutical applications.
    International journal of pharmaceutics, 2012, Feb-28, Volume: 423, Issue:2

    Topics: Chemistry, Pharmaceutical; Crystallization; Crystallography, X-Ray; Drug Carriers; Drug Compounding; Elastic Modulus; Feasibility Studies; Fenofibrate; Glycerol; Griseofulvin; Hydrogen Bonding; Hypromellose Derivatives; Kinetics; Methylcellulose; Microscopy, Electron, Scanning; Nanoparticles; Nanotechnology; Naproxen; Particle Size; Plasticizers; Solubility; Spectroscopy, Near-Infrared; Spectrum Analysis, Raman; Surface Properties; Surface-Active Agents; Technology, Pharmaceutical

2012
Impact of nanosizing on solubility and dissolution rate of poorly soluble pharmaceuticals.
    Journal of pharmaceutical sciences, 2015, Volume: 104, Issue:6

    Topics: Celecoxib; Fenofibrate; Griseofulvin; Kinetics; Nanoparticles; Nanotechnology; Pharmaceutical Preparations; Solubility; Thermodynamics; Transition Temperature

2015
Polymer strip films as a robust, surfactant-free platform for delivery of BCS Class II drug nanoparticles.
    International journal of pharmaceutics, 2015, Jul-15, Volume: 489, Issue:1-2

    Topics: Azo Compounds; Drug Delivery Systems; Fenofibrate; Glycerol; Griseofulvin; Hypromellose Derivatives; Nanoparticles; Naproxen; Phenylbutazone; Solubility

2015
Fasted-state simulated intestinal fluid "FaSSIF-C", a cholesterol containing intestinal model medium for in vitro drug delivery development.
    Journal of pharmaceutical sciences, 2015, Volume: 104, Issue:7

    Topics: Body Fluids; Caco-2 Cells; Carbamazepine; Cholesterol; Danazol; Drug Delivery Systems; Fasting; Female; Fenofibrate; Griseofulvin; Humans; Intestinal Absorption; Intestinal Mucosa; Male; Models, Theoretical; Particle Size; Solubility

2015
Octenylsuccinate hydroxypropyl phytoglycogen, a dendrimer-like biopolymer, solubilizes poorly water-soluble active pharmaceutical ingredients.
    Carbohydrate polymers, 2018, Jan-15, Volume: 180

    Topics: Celecoxib; Dendrimers; Docetaxel; Fenofibrate; Glycogen; Griseofulvin; Pharmaceutic Aids; Resveratrol; Solubility; Solvents; Stilbenes; Succinates; Surface-Active Agents; Taxoids

2018
Solubility of Pharmaceutical Ingredients in Natural Edible Oils.
    Molecular pharmaceutics, 2020, 07-06, Volume: 17, Issue:7

    Topics: Calorimetry, Differential Scanning; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Cinnarizine; Coconut Oil; Drug Compounding; Drug Delivery Systems; Excipients; Felodipine; Fenofibrate; Griseofulvin; Ibuprofen; Indomethacin; Models, Molecular; Naproxen; Plant Oils; Solubility; Soybean Oil; Spectrum Analysis, Raman; Thermodynamics; Transition Temperature; Triglycerides

2020